letrozole has been researched along with Adenomyosis in 2 studies
Adenomyosis: The extension of endometrial tissue (ENDOMETRIUM) into the MYOMETRIUM. It usually occurs in women in their reproductive years and may result in a diffusely enlarged uterus with ectopic and benign endometrial glands and stroma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Women with severe adenomyosis would benefit from letrozole or a combination of GnRHa plus letrozole before receipt of treatment with assisted reproductive technology." | 4.31 | Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis. ( Cozzolino, M; Galliano, D; Pellicer, A; Pellicer, N, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cozzolino, M | 3 |
| Pellicer, N | 3 |
| Galliano, D | 3 |
| Pellicer, A | 3 |
| Sharma, S | 1 |
| RoyChoudhury, S | 1 |
| Bhattacharya, MP | 1 |
| Hazra, S | 1 |
| Majhi, AK | 1 |
| Oswal, KC | 1 |
| Chattopadhyay, R | 1 |
1 trial available for letrozole and Adenomyosis
| Article | Year |
|---|---|
Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
Topics: Adenomyosis; Dysmenorrhea; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; L | 2023 |
1 other study available for letrozole and Adenomyosis
| Article | Year |
|---|---|
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |
Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
Topics: Adenomyosis; Aromatase Inhibitors; Estradiol; Estrogens; Female; Fertilization in Vitro; Gonadotropi | 2023 |